103
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration

, , , , , & show all
Pages 1247-1251 | Published online: 15 Jul 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.